Food and Drug Administration (FDA) Regulatory Compliance Training
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- HT9425-25-R-0050
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Place of performance
- Frederick, Maryland 21702, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The United States Army Medical Research and Development Command (USAMRDC) is seeking a contractor to provide comprehensive FDA Regulatory Compliance Training for personnel involved in FDA-regulated research activities. The Defense Health Agency is managing this solicitation, which aims to deliver training in critical regulatory areas including Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and Quality Systems Regulations (QSR). The primary objective is to help USAMRDC personnel maintain competency and compliance with FDA regulations governing product development efforts for military healthcare research. The solicitation (HT9425-25-R-0050) requires contractors to develop and conduct both introductory and refresher training courses, with proposals due by April 18, 2025. Offerors will likely be evaluated on their past performance, technical capabilities, and ability to deliver comprehensive training materials that meet stringent FDA regulatory requirements.
The contract is set aside for total small business participation and will be executed as a firm-fixed-price contract with a base year and four one-year option periods, beginning approximately May 1, 2025. Training will be conducted both virtually via Microsoft Teams and face-to-face at Fort Detrick, MD, with a maximum of 30 participants for in-person sessions and 40 participants for virtual sessions. Each training course will range from 4-8 hours, with the total number of courses varying between 4-8 per year. While specific award values are not explicitly detailed, the contract will require the contractor to provide attendance records, certificates, and comprehensive training reports after each course. The long-term goal is to support USAMRDC's mission of developing FDA-approved pharmaceuticals, devices, and biologics for U.S. Military members by ensuring personnel have the necessary regulatory knowledge and competency.
Notice text
This requirement provides competency training for personnel involved in FDA regulated research activities. The USAMRDC requires FDA regulated training in the areas of Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP) and Quality Systems Regulations (QSR).
Background:
The purpose of USAMRDC research and development activities is to provide FDA-approved pharmaceuticals and devices or licensed biologics to members of the United States (U.S) Military. These activities are governed by Federal, Department of Defense (DoD), and Army regulation and result in submissions to the FDA for eventual approval or licensure. Those research and development activities are subject to the compliance requirements of the FDA. The requirements defined in Title 21, Code of Federal Regulations (21 CFR), parts 50, 58, 211, 600, and 820, require all individuals engaged in the conduct or supervision of FDA-regulated studies have education, training, and experience, or a combination thereof, to enable the individual to perform the assigned functions. Therefore, the Command must have in place, as part of its Quality efforts, a compliance program that includes minimum standards for training of all personnel involved in FDA-regulated activities. Training requirements are outlined in accordance with USAMRDC Command Policy Memorandum 2013-60 Requirement for Training of Personnel Involved in FDA-Regulated Activities.
The USAMRDC Headquarters Principal Acquisition Assistant serves as the FDA regulated Sponsor Representative, the responsibility for fulfilling FDA regulated sponsor responsibilities, and providing this training for other Subordinate Commands. USAMRDC ORA will provide technical oversight, guidance, and management of this requirement.
Objective:
Assist personnel involved in FDA regulated product development throughout USAMRDC in maintaining competency in GCP, GLP, and cGMP to comply with U.S FDA and all other applicable DoD and Army regulations, directives, and guidance. The long-term objective of this training is to increase and maintain competency and compliance with FDA regulations governing product development efforts to meet our mission.
Files
| File | Type | Posted |
|---|---|---|
| B08. HT9425-25-R-0050+RFP Amendment 0001.docx | DOCX document | |
| B08 Attachment 1 - Non-Disclosure Agreement.docx | DOCX document | |
| B08. HT9425-25-R-0050 RFP.docx | DOCX document | |
| B08 Attachment 2 - Organizational Conflict of Interest Certification Form.docx | DOCX document | |
| B08 Attachment 3 - Past Performance References.pdf | ||
| B08 Pricing Sheet - Attachment 4.xlsx | XLSX spreadsheet |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Food and Drug Administration (FDA) Regulatory Compliance Training | Award Notice | |
| This notice | Solicitation | |
| Food and Drug Administration (FDA) Regulatory Compliance Training | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| FDA/CDRH Scientific Technical Capacity for Regulatory Review | FDA Office of Acquisition and Grant Services | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity